Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.
Full description
PRIMARY OBJECTIVES:
I. To establish a Mayo Clinic Florida Brain Tumor-Gut Axis Human Biorepository by sequential collection of fecal, urine, blood, saliva, and/or tissue samples and clinical patient information.
II. To use spatial transcriptome/proteomics/multi-omics coupled with microbiome data from various sources including brain tissue and stool samples to understand how microbiota could impact disease development, progression, and treatment response in patients with brain cancer.
III. To study the effect of microbiome and potential relationships and/or microbiome reconstruction to impact patient's clinical outcomes including chemo, radiation, immunotherapy and/or cellular therapy.
OUTLINE: This is an observational study.
Participants undergo blood, tissue, saliva, urine and stool sample collection and complete questionnaires on study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study.
Exclusion criteria
- Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.
Trial design
100 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Clinical Trials Referral Office
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal